This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
The investigators for this report were James B. Spies, M.D.; Evan R. Meyers, M.D., M.P.H.; Jyotsna Mulgund, M.S.; Keith M. Hume, M.A.; and Carolyn Strain.
Analysis of the FIBROID Registry data for this report was supported by AHRQ and the FDA Office of Women's Health through Contract No. 03R00027101D. The Project Officer was Rosaly Correa-de-Araujo, M.D., M.Sc., Ph.D.
|The authors of this report are responsible for its content. Statements made in the report should not be construed as an endorsement by AHRQ, the FDA, or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service.
Return to Contents
AHRQ Publication No. 05(06)-RG008
Current as of October 2005